Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07244458Not ApplicableRecruiting

Dietary Peanuts and Nutrition-Related Outcomes

Role: lead

NCT07244445Not ApplicableRecruiting

Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

Role: lead

NCT05933174Not ApplicableRecruiting

Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

Role: lead

NCT05523362Not ApplicableCompleted

Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes

Role: lead

All 4 trials loaded